BindingDB logo
myBDB logout

BDBM50061271 (2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yloxycarbonylamino)-3-(1H-indol-3-yl)-2-methyl-propionyl]-4-(4-chloro-phenoxy)-pyrrolidine-2-carboxylic acid::CHEMBL435404

SMILES: C[C@](Cc1c[nH]c2ccccc12)(NC(=O)ON1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N1C[C@@H](C[C@@H]1C(O)=O)Oc1ccc(Cl)cc1

InChI Key: InChIKey=XKNKIJOITBWHMM-KYAQRFMDSA-N

Data: 2 KI  1 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50061271   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
CCKBR


(RAT)
BDBM50061271
PNG
((2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-...)
Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)ON1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N1C[C@@H](C[C@@H]1C(O)=O)Oc1ccc(Cl)cc1 |TLB:25:17:24:21.22.20,15:16:22:19.24.20,THB:18:17:22:19.24.20,18:19:22:16.17.25,15:16:24:21.22.20|
Show InChI InChI=1S/C33H37ClN4O6/c1-33(16-21-17-35-28-5-3-2-4-27(21)28,36-32(42)44-38-23-11-19-10-20(13-23)14-24(38)12-19)31(41)37-18-26(15-29(37)30(39)40)43-25-8-6-22(34)7-9-25/h2-9,17,19-20,23-24,26,29,35H,10-16,18H2,1H3,(H,36,42)(H,39,40)/t19-,20+,23-,24+,26-,29-,33-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
24n/an/an/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Compound was tested for the affinity against Cholecystokinin type B receptor on guinea pig cortex.


J Med Chem 40: 3947-56 (1998)


Article DOI: 10.1021/jm970439a
BindingDB Entry DOI: 10.7270/Q27H1K8Z
More data for this
Ligand-Target Pair
Cholecystokinin receptor


(Homo sapiens (Human))
BDBM50061271
PNG
((2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-...)
Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)ON1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N1C[C@@H](C[C@@H]1C(O)=O)Oc1ccc(Cl)cc1 |TLB:25:17:24:21.22.20,15:16:22:19.24.20,THB:18:17:22:19.24.20,18:19:22:16.17.25,15:16:24:21.22.20|
Show InChI InChI=1S/C33H37ClN4O6/c1-33(16-21-17-35-28-5-3-2-4-27(21)28,36-32(42)44-38-23-11-19-10-20(13-23)14-24(38)12-19)31(41)37-18-26(15-29(37)30(39)40)43-25-8-6-22(34)7-9-25/h2-9,17,19-20,23-24,26,29,35H,10-16,18H2,1H3,(H,36,42)(H,39,40)/t19-,20+,23-,24+,26-,29-,33-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
24n/an/an/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Compound was tested for binding affinity against rat brain Cholecystokinin type B receptor expressed in CHO cells.


J Med Chem 40: 3947-56 (1998)


Article DOI: 10.1021/jm970439a
BindingDB Entry DOI: 10.7270/Q27H1K8Z
More data for this
Ligand-Target Pair
CCKBR


(RAT)
BDBM50061271
PNG
((2R,4R)-1-[(R)-2-(2-Aza-tricyclo[3.3.1.1*3,7*]dec-...)
Show SMILES C[C@](Cc1c[nH]c2ccccc12)(NC(=O)ON1[C@H]2C[C@@H]3C[C@@H](C[C@H]1C3)C2)C(=O)N1C[C@@H](C[C@@H]1C(O)=O)Oc1ccc(Cl)cc1 |TLB:25:17:24:21.22.20,15:16:22:19.24.20,THB:18:17:22:19.24.20,18:19:22:16.17.25,15:16:24:21.22.20|
Show InChI InChI=1S/C33H37ClN4O6/c1-33(16-21-17-35-28-5-3-2-4-27(21)28,36-32(42)44-38-23-11-19-10-20(13-23)14-24(38)12-19)31(41)37-18-26(15-29(37)30(39)40)43-25-8-6-22(34)7-9-25/h2-9,17,19-20,23-24,26,29,35H,10-16,18H2,1H3,(H,36,42)(H,39,40)/t19-,20+,23-,24+,26-,29-,33-/m1/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 72n/an/an/an/an/an/a



INSERM

Curated by ChEMBL


Assay Description
Inhibition of inositol phosphate production induced by Cholecystokinin type B receptor (0.5 nM)


J Med Chem 40: 3947-56 (1998)


Article DOI: 10.1021/jm970439a
BindingDB Entry DOI: 10.7270/Q27H1K8Z
More data for this
Ligand-Target Pair